Home/Filings/4/0001209191-20-059697
4//SEC Filing

Turgeon Joseph W. 4

Accession 0001209191-20-059697

CIK 0000831547other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:10 PM ET

Size

6.3 KB

Accession

0001209191-20-059697

Insider Transaction Report

Form 4
Period: 2020-11-18
Turgeon Joseph W.
Chief Commercial Officer
Transactions
  • Sale

    Common Stock, $0.001 par value

    2020-11-18$4.13/sh162,473$671,013528,661 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    1,538
Footnotes (2)
  • [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 to $4.24, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeother

Related Parties

1
  • filerCIK 0001574659

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:10 PM ET
Size
6.3 KB